KOSDAQ · Healthcare · ₩32B
₩1,582+0.25%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.2% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“유럽 판매길을 넓혔고 이제 실제 주문이 중요해졌어요.”
In the company's words · 2026 2분기 filing